We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. No prescription was prescribed in 82% of the dermatology ...

Patients with onychomycosis who are treated with topical urea 40% in addition to antifungal therapy may have improved clinical cure rates.

WASHINGTON, Jan. 31, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug ...

Please provide your email address to receive an email when new articles are posted on . Treatment efficacy was achieved by 76.67% of the continuous regimen group vs. 26.67% of the pulsed group (P = ...

Moberg Pharma is developing MOB-015, which is believed to be the most successful therapy amongst all the other expected drug candidates and shall account for the highest Onychomycosis market revenue ...

Onychomycosis is the most common disease of nails, with a prevalence of up to 14% in Western adult populations. Whereas tinea unguium refers strictly to dermatophyte fungal infection of the nail plate ...

LOS ALTOS, Calif.--(BUSINESS WIRE)--TOPICA Pharmaceuticals, Inc., a privately held biotechnology company, today announced that it’s ready to advance its 10% solution of luliconazole into Phase 3 ...

Toenail fungus, or onychomycosis, is a nail infection that can make your toenails thicker, change color, or break apart. It affects about one in 10 people and is common in adults over 60. While fungi ...

PEWAUKEE, Wis., May 15, 2025 /PRNewswire/ -- BiaCure Therapies, an emerging innovator in non-invasive medical technology, today announced it has been awarded a Small Business Innovation Research (SBIR ...